查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1985982

全球神经血管医疗设备市场：市场规模、份额和趋势分析（按器材、治疗应用、最终用途和地区划分），基于细分市场的预测（2026-2033 年）

Neurovascular Devices Market Size, Share & Trends Analysis Report By Device, By Therapeutic Applications, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

神经血管医疗设备市场概述

2025年全球神经血管医疗设备市场规模估计为77.8亿美元，预计2033年将达到119.1亿美元。

预计从 2026 年到 2033 年，该市场将以 5.40% 的复合年增长率成长。推动该市场成长的因素包括神经血管疾病的日益普遍、医疗技术的进步以及人们对微创手术日益增长的兴趣。

随着中风、脑动脉瘤和动静脉畸形（AVM）等疾病的日益常见，对有效治疗方法的需求也随之增长。中风和动脉瘤等神经血管疾病盛行率的上升是推动市场发展的主要因素。包括血栓切除装置、微导管和血流导引弹簧圈在内的多种神经血管医疗设备被用来治疗这些疾病。根据世界卒中组织（WSO）发布的《2024年全球卒中概况》，每年新增中风病例超过1200万例，预计全球约有25%的人口在其一生中的某个阶段会经历中风。

中风等神经血管疾病造成的负担正在显着增加，预计这将推动对神经血管医疗设备，包括神经血栓切除器械，如血栓切除设备和抽吸装置。

此外，根据脑动脉瘤基金会2024年8月发布的数据，美国约有680万人患有未破裂的脑动脉瘤，每年约有3万人发生脑动脉瘤破裂。因此，神经血管疾病患者数量的激增以及神经血管医疗设备在治疗中的日益普及，预计将在未来几年推动市场成长。

目录

第一章：分析方法和范围

第二章执行摘要

第三章：神经血管医疗设备市场：影响因素、趋势与范围

  • 市场历史及展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 神经血管医疗设备分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章 神经血管医疗设备市场：细分市场分析、器材类型（2021-2033 年）

  • 定义和范围
  • 市场占有率分析：按设备类型划分（2025 年和 2033 年）
  • 全球神经血管医疗设备市场：依器材类型划分（2021-2033 年）
  • 市场规模、预测与趋势分析（2021-2033）

第五章：神经血管医疗设备市场：按治疗应用分類的细分市场分析（2021-2033 年）

  • 定义和范围
  • 市占率分析：依治疗应用划分（2025 年和 2033 年）
  • 全球神经血管医疗设备市场：依治疗应用划分（2021-2033 年）
  • 市场规模、预测与趋势分析（2021-2033）

第六章 神经血管医疗设备市场：依最终用途分類的细分市场分析（2021-2033 年）

  • 定义和范围
  • 市场占有率分析：依最终用途划分（2025 年和 2033 年）
  • 全球神经血管医疗设备市场：依最终用途划分（2021-2033 年）
  • 市场规模、预测与趋势分析（2021-2033）

第七章：神经血管医疗设备市场：区域估算与趋势分析

  • 区域仪錶板
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 近期趋势及影响分析：依主要市场参与企业
  • 公司/竞争对手分类
    • 创新者
  • 供应商情况
    • 主要销售代理商和通路伙伴名单
    • 主要客户
    • 主要企业：市占率分析（2025 年）
    • Medtronic
    • Stryker
    • Terumo Corporation
    • Penumbra, Inc.
    • Johnson &Johnson and its affiliates
    • MicroPort Scientific Corporation
    • Acandis GmbH
    • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • NeuroSafe Medical Co., Ltd.
    • Rapid Medical
    • Evasc Neurovascular Enterprises
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • phenox GmbH（Wallaby Medical）
  • 公司热力图分析/市场分析
  • 企业市场占有率分析（2025 年估计值）
  • 其他主要企业名单
Product Code: GVR-2-68038-851-0

Neurovascular Devices Market Summary

The global neurovascular devices market size was estimated at USD 7.78 billion in 2025 and is projected to reach USD 11.91 billion by 2033, growing at a CAGR of 5.40% from 2026 to 2033. The market is driven by the rising prevalence of neurovascular disorders, advancements in medical technology, and an increasing focus on minimally invasive procedures.

As conditions such as stroke, cerebral aneurysms, and Arteriovenous Malformations (AVM) become more common, the demand for effective treatment options also increases. The increasing prevalence of neurovascular diseases such as strokes and aneurysms is a major driving force behind the market. Various neurovascular devices, including clot retrieval devices, microcatheters, and flow diversion coils, are utilized to treat these conditions. According to the Global Stroke Fact Sheet 2024 published by the World Stroke Organization (WSO), more than 12 million new strokes occur annually, and about 25% of the global population will experience a stroke in their lifetime.

The burden of neurovascular disorders such as strokes is increasing significantly, which is anticipated to propel the demand for neurovascular devices such as neurothrombectomy devices like clot retrievers and suction devices, among others.

In addition, data released by the Brain Aneurysm Foundation in August 2024 indicates that an unruptured brain aneurysm affects an estimated 6.8 million people in the U.S., with around 30,000 individuals suffering a brain aneurysm rupture each year. As a result, the significant number of patients affected by neurovascular diseases and the increasing use of neurovascular devices in their treatment are expected to drive market growth in the coming years.

Global Neurovascular Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurovascular devices market report based on device, application, end use, and region:

  • Device Outlook (Revenue USD Million, 2021 - 2033)
  • Cerebral Embolization and Aneurysm Coiling Devices
    • Embolic coils
    • Flow diversion devices
    • Liquid embolic agents
  • Cerebral Angioplasty and Stenting Systems
    • Carotid artery stents
    • Embolic protection systems
  • Neurothrombectomy Devices
    • Clot retrieval devices
    • Suction devices/aspiration catheters
    • Vascular snares
  • Support Devices
    • By Size
    • 0.027"
    • 0.021"
    • 0.071"
    • 0.017"
    • 0.019"
    • 0.013"
    • 0.058"
    • 0.068"
    • Others
    • By Product
    • Micro catheters
    • Micro guidewires
  • Trans Radial Access Devices
  • Therapeutic Application Outlook (Revenue USD Million, 2021 - 2033)
  • Stroke
  • Cerebral Artery
  • Cerebral Aneurysm
    • Aneurysmal Subarachnoid Hemorrhage
    • Others
  • Others
  • End Use Outlook (Revenue USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Others
  • Regional Outlook (Revenue USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Device
    • 1.2.2. Therapeutic Applications
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Neurovascular Devices Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Neurovascular Diseases
      • 3.2.1.2. Technological Advancements In Neurovascular Devices
      • 3.2.1.3. Rising Number of Awareness Initiatives
      • 3.2.1.4. Increasing Demand For Minimally Invasive Procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product Recalls
      • 3.2.2.2. High Treatment Cost Associated With Neurovascular Disorders
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing Number of Clinical Trials
      • 3.2.3.2. Launches Of Novel Products
      • 3.2.3.3. Increasing Research & Development Activities
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Shortage of Skilled Professionals
      • 3.2.4.2. Potential Complications & Risks associated with Neurovascular Devices
  • 3.3. Neurovascular Devices Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Devices Market: Segment Analysis, By Device, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Segment Dashboard
  • 4.3. Device Market Share Analysis, 2025 & 2033
  • 4.4. Global Neurovascular Devices Market, by Device, 2021 to 2033
  • 4.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 4.5.1. Cerebral Embolization and Aneurysm coiling devices
      • 4.5.1.1. Cerebral embolization and aneurysm coiling devices market, 2021 - 2033 (USD Million)
      • 4.5.1.2. Embolic coils
        • 4.5.1.2.1. Embolic coils market, 2021 - 2033 (USD Million)
      • 4.5.1.3. Flow diverters
        • 4.5.1.3.1. Flow diverters market, 2021 - 2033 (USD Million)
      • 4.5.1.4. Liquid embolic agents
        • 4.5.1.4.1. Liquid embolic agents market, 2021 - 2033 (USD Million)
    • 4.5.2. Cerebral angioplasty and stenting systems
      • 4.5.2.1. Cerebral angioplasty and stenting systems market, 2021 - 2033 (USD Million)
      • 4.5.2.2. Carotid Artery Stents
        • 4.5.2.2.1. Carotid artery stents market, 2021 - 2033 (USD Million)
      • 4.5.2.3. Embolic Protection Devices
        • 4.5.2.3.1. Embolic protection systems devices market, 2021 - 2033 (USD Million)
    • 4.5.3. Neurothrombectomy devices
      • 4.5.3.1. Neurothrombectomy devices market, 2021 - 2033 (USD Million)
      • 4.5.3.2. Clot Retrieval Devices
        • 4.5.3.2.1. Clot retrieval devices market, 2021 - 2033 (USD Million)
      • 4.5.3.3. Suction Devices
        • 4.5.3.3.1. Suction devices market, 2021 - 2033 (USD Million)
      • 4.5.3.4. Vascular Snares
        • 4.5.3.4.1. Vascular snares market, 2021 - 2033 (USD Million)
    • 4.5.4. Support devices
      • 4.5.4.1. Support devices market, 2021 - 2033 (USD Million)
      • 4.5.4.2. By Product
        • 4.5.4.2.1. Micro Catheters
          • 4.5.4.2.1.1. Micro catheters market, 2021 - 2033 (USD Million)
        • 4.5.4.2.2. Micro Guidewires
          • 4.5.4.2.2.1. Micro guidewires market, 2021 - 2033 (USD Million)
      • 4.5.4.3. By Size
        • 4.5.4.3.1. 0.027"
          • 4.5.4.3.1.1. 0.027" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.2. 0.021"
          • 4.5.4.3.2.1. 0.021" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.3. 0.071"
          • 4.5.4.3.3.1. 0.071" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.4. 0.017"
          • 4.5.4.3.4.1. 0.017" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.5. 0.019"
          • 4.5.4.3.5.1. 0.019" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.6. 0.013"
          • 4.5.4.3.6.1. 0.013" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.7. 0.058"
          • 4.5.4.3.7.1. 0.058" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.8. 0.068"
          • 4.5.4.3.8.1. 0.068" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.9. Others
          • 4.5.4.3.9.1. Others market, 2021 - 2033 (USD Million)
    • 4.5.5. Trans Radial Access Devices
      • 4.5.5.1. Trans radial access devices market, 2021 - 2033 (USD Million)

Chapter 5. Neurovascular Devices Market: Segment Analysis, By Therapeutic Applications, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Segment Dashboard
  • 5.3. Therapeutic Applications Market Share Analysis, 2025 & 2033
  • 5.4. Global Neurovascular Devices Market, by Therapeutic Applications, 2021 to 2033
  • 5.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 5.5.1. Stroke
      • 5.5.1.1. Stroke market, 2021 - 2033 (USD Million)
    • 5.5.2. Cerebral artery stenosis
      • 5.5.2.1. Cerebral artery stenosis market, 2021 - 2033 (USD Million)
    • 5.5.3. Cerebral aneurysm
      • 5.5.3.1. Cerebral aneurysm market, 2021 - 2033 (USD Million)
      • 5.5.3.2. Aneurysmal Subarachnoid Hemorrhage
        • 5.5.3.2.1. Aneurysmal subarachnoid hemorrhage market, 2021 - 2033 (USD Million)
      • 5.5.3.3. Others
        • 5.5.3.3.1. Others market, 2021 - 2033 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market, 2021 - 2033 (USD Million)

Chapter 6. Neurovascular Devices Market: Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Segment Dashboard
  • 6.3. End Use Market Share Analysis, 2025 & 2033
  • 6.4. Global Neurovascular Devices Market, by End Use, 2021 to 2033
  • 6.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 6.5.1. Hospital
      • 6.5.1.1. Hospital market, 2021 - 2033 (USD Million)
    • 6.5.2. Specialty clinics
      • 6.5.2.1. Specialty clinics market, 2021 - 2033 (USD Million)
    • 6.5.3. Others
      • 6.5.3.1. Others market, 2021 - 2033 (USD Million)

Chapter 7. Neurovascular Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Global Key company market share analysis, 2025
    • 8.3.4. Medtronic
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Stryker
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Terumo Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Penumbra, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Johnson & Johnson and its affiliates
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. MicroPort Scientific Corporation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Acandis GmbH
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. NeuroSafe Medical Co., Ltd.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Rapid Medical
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Evasc Neurovascular Enterprises
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Lepu Medical Technology(Beijing) Co., Ltd.
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives
    • 8.3.16. phenox GmbH (Wallaby Medical)
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial performance
      • 8.3.16.3. Product benchmarking
      • 8.3.16.4. Strategic initiatives
  • 8.4. Heat Map Analysis/ Company Market Position Analysis
  • 8.5. Estimated Company Market Share Analysis, 2025
  • 8.6. List of Other Key Market Players-

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 4. North America neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 5. North America neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 6. North America neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 7. U.S. neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 8. U.S. neurovascular devices, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 9. U.S. neurovascular devices, by end use, 2021 - 2033 (USD Million)
  • Table 10. Canada neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 11. Canada neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 12. Canada neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 13. Mexico neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 14. Mexico neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 15. Mexico neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16. Europe neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 17. Europe neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 18. Europe neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 19. Europe neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 20. Europe neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 21. UK neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 22. UK neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 23. UK neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 24. Germany neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 25. Germany neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 26. Germany neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 27. France neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 28. France neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 29. France neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 30. Italy neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 31. Italy neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 32. Italy neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 33. Spain neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 34. Spain neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 35. Spain neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 36. Spain neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 37. Norway neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 38. Norway neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 39. Norway neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 40. Sweden neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 41. Sweden neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 42. Sweden neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 43. Denmark neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 44. Denmark neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 45. Denmark neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 46. Asia Pacific neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 50. China neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 51. China neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 52. China neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 53. Japan neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 54. Japan neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 55. Japan neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 56. India neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 57. India neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 58. India neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 59. Australia neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 60. Australia neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 61. Australia neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 62. South Korea neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 63. South Korea neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 64. Thailand neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 65. Thailand neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 66. Thailand neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 67. Thailand neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 68. Latin America neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 69. Latin America neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 70. Latin America neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 71. Latin America neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 72. Brazil neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 73. Brazil neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 74. Brazil neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 75. Argentina neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 76. Argentina neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 77. Argentina neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 78. Middle East & Africa neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 82. South Africa neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 83. South Africa neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 84. South Africa neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 85. Saudi Arabia neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 86. Saudi Arabia neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 88. UAE neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 89. UAE neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 90. UAE neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 91. Kuwait neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 92. Kuwait neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 93. Kuwait neurovascular devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Neurovascular devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2025)
  • Fig. 10 Segment Outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 17 Neurovascular devices market: Device movement analysis
  • Fig. 18 Neurovascular devices market device outlook: Key takeaways
  • Fig. 19 Cerebral embolization and aneurysm coiling devices market, 2021 - 2033 (USD Million)
  • Fig. 20 Embolic coils market, 2021 - 2033 (USD Million)
  • Fig. 21 Flow diverters market, 2021 - 2033 (USD Million)
  • Fig. 22 Liquid embolic agents market, 2021 - 2033 (USD Million)
  • Fig. 23 Cerebral angioplasty and stenting systems market, 2021 - 2033 (USD Million)
  • Fig. 24 Carotid artery stents market, 2021 - 2033 (USD Million)
  • Fig. 25 Embolic protection systems devices market, 2021 - 2033 (USD Million)
  • Fig. 26 Neurothrombectomy devices market, 2021 - 2033 (USD Million)
  • Fig. 27 Clot retrieval devices market, 2021 - 2033 (USD Million)
  • Fig. 28 Suction devices market, 2021 - 2033 (USD Million)
  • Fig. 29 Vascular snares market, 2021 - 2033 (USD Million)
  • Fig. 30 Support devices market, 2021 - 2033 (USD Million)
  • Fig. 31 Micro catheters market, 2021 - 2033 (USD Million)
  • Fig. 32 Guidewires market, 2021 - 2033 (USD Million)
  • Fig. 33 Size market, 2021 - 2033 (USD Million)
  • Fig. 34 0.027"market, 2021 - 2033 (USD Million)
  • Fig. 35 0.021" market, 2021 - 2033 (USD Million)
  • Fig. 36 0.021" market, 2021 - 2033 (USD Million)
  • Fig. 37 0.071" market, 2021 - 2033 (USD Million)
  • Fig. 38 0.046" market, 2021 - 2033 (USD Million)
  • Fig. 39 0.019" market, 2021 - 2033 (USD Million)
  • Fig. 40 0.013" market, 2021 - 2033 (USD Million)
  • Fig. 41 0.058" market, 2021 - 2033 (USD Million)
  • Fig. 42 0.068" market, 2021 - 2033 (USD Million)
  • Fig. 43 Others market, 2021 - 2033 (USD Million)
  • Fig. 44 Trans radial access devices market, 2021 - 2033 (USD Million)
  • Fig. 45 Neurovascular devices market: Therapeutic application movement analysis
  • Fig. 46 Neurovascular devices market therapeutic applications outlook: Key takeaways
  • Fig. 47 Stroke market, 2021 - 2033 (USD Million)
  • Fig. 48 Cerebral artery stenosis market, 2021 - 2033 (USD Million)
  • Fig. 49 Cerebral aneurysm market, 2021 - 2033 (USD Million)
  • Fig. 50 Aneurysmal subarachnoid hemorrhage market, 2021 - 2033 (USD Million)
  • Fig. 51 Others market, 2021 - 2033 (USD Million)
  • Fig. 52 Others market, 2021 - 2033 (USD Million)
  • Fig. 53 Neurovascular devices market: End use movement analysis
  • Fig. 54 Neurovascular devices market end use outlook: Key takeaways
  • Fig. 55 Hospital market, 2021 - 2033 (USD Million)
  • Fig. 56 Specialty clinics market, 2021 - 2033 (USD Million)
  • Fig. 57 Others market, 2021 - 2033 (USD Million)
  • Fig. 58 Regional outlook, 2025 & 2033
  • Fig. 59 North America neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 60 U.S. neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 61 Canada neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 62 Mexico neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 63 Europe neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 64 UK neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 65 Germany neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 66 France neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 67 Italy neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 68 Spain neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 69 Norway neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 70 Denmark neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 71 Sweden neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 72 Asia Pacific neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 73 Japan neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 74 China neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 75 India neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 76 Australia neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 77 South Korea neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 78 Thailand neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 79 Latin America neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 80 Brazil neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 81 Argentina neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 82 MEA neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 83 South Africa neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 84 Saudi Arabia neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 85 UAE neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 86 Kuwait neurovascular devices market, 2021 - 2033 (USD Million)